Did Jim Cramer Get These 23 Stocks Right?

16. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Holders: 98

While mentioning different companies that were partnering up with Nvidia at the time, Johnson & Johnson (NYSE:JNJ) was one of them:

“J&J came up many times with its operating room of the future, but if you buy that one, you’re playing litigation roulette.”

Johnson & Johnson (NYSE:JNJ) has increased by 5.82% since Cramer mentioned it.

Here’s what Jim Cramer said about the stock on the 14^th of March:

“J&J has risen significantly and is at a critical point where it could either break out or be rejected. These three companies have been artificially inflated by a program that shifted from high-performing stocks to these companies, including J&J, which has had suboptimal performance. J&J needs to return to the 160 level. These companies are not performing well enough to justify their rallies, which have been driven by traders who seem to execute trades without proper strategy. Had the orders been managed differently, this action would not have occurred.”